🇺🇸 FDA
Pipeline program

INSULIN GLARGINE (HOE901)

LANTU_L_04264

Approved small_molecule terminated

Quick answer

INSULIN GLARGINE (HOE901) for Diabetes Mellitus, Type 2 is a Approved program (small_molecule) at Sanofi Pasteur with 1 ClinicalTrials.gov record(s).

Program details

Company
Sanofi Pasteur
Indication
Diabetes Mellitus, Type 2
Phase
Approved
Modality
small_molecule
Status
terminated

Clinical trials